GlassScriptPhysician profile
Robert G Kadoko
NPI 1427039445
$4,464.19
in general payments reported to CMS, 2019-2025
24 companies · $505 in 2025
The $505 reported for 2025 was less than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,677 · 2020: $134 · 2021: $86.09 · 2022: $94.25 · 2023: $1,583 · 2024: $386 · 2025: $505.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $1,262 · Food and Beverage: $1,211.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $1,262.05 |
| Food and Beverage | $1,210.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Encore Medical, LP | $2,311.54 | 2019-2023 | Djo Surgical |
| Depuy Synthes Sales INC. | $637.33 | 2019-2025 | Na, Lcp, Tfn-Advance |
| Advanced Orthopaedic Solutions, INC. | $236.16 | 2019 | |
| Smith+Nephew, INC. | $149.71 | 2019-2025 | T-Max, Acufex Meniscal Root Repair, Novostitch |
| Pacira Therapeutics, INC. | $125.47 | 2019-2021 | |
| Bioventus LLC | $117.69 | 2019-2025 | Durolane |
| Acumed LLC | $115.24 | 2024-2025 | Acumed, Acumed |
| Stryker Corporation | $100.23 | 2019-2025 | Accolade, Insignia, Pangea |
| Ethicon US, LLC | $99.07 | 2023-2025 | Stratafix, Dermabond Prineo, Dermabond |
| Ferring Pharmaceuticals INC. | $97.71 | 2025 | Euflexxa |
| Orthofix Medical, INC. | $74.44 | 2020-2024 | Physio-Stim |
| Pylant Medical | $73.58 | 2021-2023 | |
| Globus Medical, INC. | $69.17 | 2023 | Distal Femur Plate System, Proximal Tibia Plate |
| Mimedx Group, INC. | $45.72 | 2024-2025 | |
| Pacira Pharmaceuticals Incorporated | $43.88 | 2020-2022 |
Show all 24 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Illuminoss Medical, INC. | $38.51 | 2019 | |
| Abbott Laboratories | $24.23 | 2022 | |
| Kerecis Limited | $19.55 | 2023 | Kerecis Omega3 Surgiclose, Kerecis Omega3 Marigen, Kerecis Omega3 Graftguide |
| Heron Therapeutics, INC. | $17.94 | 2025 | Zynrelef |
| Kowa Pharmaceuticals America, INC. | $16.15 | 2023 | Seglentis |
| Acell, INC. | $13.89 | 2019 | |
| Amgen INC. | $13.02 | 2019 | |
| Sanofi-Aventis U.S. LLC | $12.59 | 2019 | |
| Ermi LLC | $11.37 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Robert Kadoko listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.